TriAxis Biosciences

How we’re validating the platform

Field claims must be earned in the data first.

Before any deployment, our platform must demonstrate — measurably and reproducibly — that the wastewater signal anticipates clinical resistance trends. Our validation approach pairs the platform against curated, published wastewater metagenomic datasets and contemporaneous clinical AMR surveillance data.

The goal is a rigorous, defensible measurement of lead time before we make any field claim. Methods will be shared through peer-reviewed publication.

Where we are now

We are currently in Phase 01 — building and running the validation platform against published datasets. No field pilots, no public dashboards, and no deployment claims will be made until the validation work is complete and published.

Interested in the work?

Help us build the early-warning system AMR needs.

Partner with us →